Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 6, 2001, Pages 1172-1178

  Ishihama, H ^a   Ohbayashi, M ^a   Kurosawa, N ^a   Kitsukawa, T ^a   Matsuura, O ^a   Miyake, Y ^a   Muramatsu, T ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROPILIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISCHEMIA; MOUSE; NONHUMAN; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RETINOPATHY; TISSUE DISTRIBUTION;

ANIMALS; DNA PRIMERS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEUROPILIN-1; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035028183     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Retinopathy of prematurity-induced blindness: Birth weight-specific survival and the new epidemic
2. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
3. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
4. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor
5. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
6. The mode of development of vascular system of retina, with some observations on its significance for certain retinal disease
7. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia
8. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
9. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
10. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
11. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
12. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
13. Vascular endothelial growth factor (VEGF) and its receptors
14. Signal relays in the VEGF system
15. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
16. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
17. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
18. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
19. Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies
20. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors
21. Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system
22. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system
23. Neuropilin is a receptor for the axonal chemorepellent semaphorin III
24. Neuropilin is a semaphorin III receptor
25. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
26. Neuropilin-2 is a receptor for semaphorin IV: Insight into the structural basis of receptor function and specificity
27. Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF
28. Oxygen-induced retinopathy in the mouse
29. Expression of basigin, a member of the immunoglobulin superfamily, in the mouse central nervous system
30. Neointima formation in a restenosis model is suppressed in midkine-deficient mice
31. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs
32. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice
33. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors
34. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression
35. Expression and regulation of neuropilin-1 in human astrocytomas
36. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
37. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
38. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells